TCI Wealth Advisors’s TherapeuticsMD TXMD Stock Holding History

TCI Wealth Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-26	Closed	–	–	2519
2022 Q1	$0	Hold	26	–	–	﹤0.01%	2454
2021 Q4	$0	Hold	26	–	–	﹤0.01%	2525
2021 Q3	$1K	Hold	26	–	–	﹤0.01%	2317
2021 Q2	$2K	Hold	26	–	–	﹤0.01%	2106
2021 Q1	$2K	Hold	26	–	–	﹤0.01%	1911
2020 Q4	$2K	Hold	26	–	–	﹤0.01%	1282
2020 Q3	$2K	Hold	26	–	–	﹤0.01%	1190
2020 Q2	$2K	Hold	26	–	–	﹤0.01%	1136
2020 Q1	$1K	Hold	26	–	–	﹤0.01%	1356
2019 Q4	$3K	Hold	26	–	–	﹤0.01%	1058
2019 Q3	$5K	Hold	26	–	–	﹤0.01%	827
2019 Q2	$3K	Buy	+26	New	+$4.66K	﹤0.01%	936

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

TCI Wealth Advisors's TXMD Position: Q2 2022 in Review

TCI Wealth Advisors sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 26 shares.

TCI Wealth Advisors first reported a position in TXMD in Q2 2019 and held it in 12 quarters. The position peaked at $5K in Q3 2019. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

TCI Wealth Advisors reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
TCI Wealth Advisors sold 26 TherapeuticsMD shares in Q2 2022.
TCI Wealth Advisors first reported a position in TherapeuticsMD in Q2 2019 and held it in 12 quarters.
TCI Wealth Advisors's TherapeuticsMD position peaked at $5K in Q3 2019.
53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.